GuidelineSuperseded
ASH 2019 — American Society of Hematology 2019 Guidelines for Immune Thrombocytopenia
American Society of Hematology, 2019
This guideline has been superseded by a newer recommendation. Check the Knowledge Map or the current topic page for the guideline that replaces it.
ITP treatment is driven by bleeding, platelet count, comorbidity and need for procedures rather than the platelet count alone; corticosteroids and IVIG are core rapid therapies, with escalation individualized for severe or refractory disease.
Conditional recommendationModerate certainty
View source guideline